Get the Stockscreener App
68.44
2.31%
-1.62
Henry Schein Inc stock is traded at $68.44, with a volume of 419.94K.
It is down -2.31% in the last 24 hours and down -8.84% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
See More
Previous Close:
$70.06
Open:
$69.95
24h Volume:
419.94K
Relative Volume:
0.28
Market Cap:
$8.70B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
20.01
EPS:
3.42
Net Cash Flow:
$421.00M
1W Performance:
-6.48%
1M Performance:
-8.84%
6M Performance:
+1.74%
1Y Performance:
-8.65%
1-Day Range:
$69.44
$70.24
1-Week Range:
$68.42
$73.44
52-Week Range:
$63.67
$82.63
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
70.01 | 8.70B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
579.13 | 73.26B | 330.19B | 2.54B | 4.31B | 19.31 |
|
COR
Cencora Inc
|
227.54 | 43.92B | 293.96B | 1.51B | 3.00B | 7.51 |
|
CAH
Cardinal Health Inc
|
118.83 | 28.65B | 224.34B | 1.26B | 1.08B | 5.14 |
|
PDCO
Patterson Companies Inc
|
30.91 | 2.73B | 6.53B | 168.41M | -885.03M | 1.83 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein Inc. stock rises Monday, still underperforms market - MarketWatch
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
In brief: No reimbursement relief, MGA Homecare deal, Henry Schein ‘Cheer’ - HME News
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Henry Schein brings ‘Holiday Cheer’ - HME News
Should You Retain Henry Schein Stock in Your Portfolio Right Now? - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Henry Schein, Inc. (NASDAQ:HSIC) Potentially Undervalued? - Yahoo Finance
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
How Is The Market Feeling About Henry Schein? - Benzinga
Henry Schein to Participate at J.P. Morgan’s Healthcare Investor Conference - Dentistry Today
Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $78.89 - MarketBeat
Henry Schein to Present at J.P. Morgan Healthcare Conference 2025: Healthcare Solutions Leader Takes Center Stage - StockTitan
Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue? - MSN
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein, Inc.'s (NASDAQ:HSIC) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Simply Wall St
Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Barclays PLC - MarketBeat
Toronto Dominion Bank Has $4.58 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why Henry Schein (HSIC) is a Strong Value Stock - MSN
On Our Island: Henry Schein spreads holiday cheer to LI families - Long Island Business News
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players? - Benzinga
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now (NASDAQ:HSIC) - Seeking Alpha
Foyston Gordon & Payne Inc Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
State Street Corp Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by National Bank of Canada FI - MarketBeat
Henry Schein Acquires Acentus to Expand Homecare Medical Supplies Market - The Healthcare Technology Report.
Stifel Financial Corp Boosts Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Edgestream Partners L.P. - MarketBeat
Centiva Capital LP Sells 15,802 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Mizuho sets Henry Schein target at $75 with neutral stance By Investing.com - Investing.com Canada
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts - Benzinga
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Holocene Advisors LP Acquires Shares of 799,981 Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Atom Investors LP Sells 8,543 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
New VeneerNow™ Injectable Matrix System Designed to Simplify Anterior Composite Restorations - Dental Products Report
Fmr LLC Buys 237,888 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
BNP Paribas Financial Markets Acquires 9,465 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet? - Simply Wall St
Isthmus Partners LLC Invests $701,000 in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Bridgewater Associates LP Has $4.32 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein extends gain on report of activist stake, push for board changes - MSN
Citigroup Inc. Trims Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
HSIC Gears Up for Q3 Earnings: Here's What You Need to Know - MSN
Zacks Research Forecasts Increased Earnings for Henry Schein - MarketBeat
FORA Capital LLC Buys 9,412 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Makes New $43.74 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Bank of Montreal Can Boosts Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - MSN
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
11.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):